BofA Downgrades Pinduoduo On Monetization Concerns

Priya Nigam

Wed, May 20, 2020, 4:19 PM2 min read

In this article:

Pinduoduo Inc – ADR (NASDAQ: PDD) is scheduled to report first-quarter results Friday.

While the Chinese e-commerce company company is likely to report its topline numbers broadly in-line with expectations, there are concerns surrounding monetization and profits, according to BofA Securities.

The Pinduoduo Analyst

Joyce Ju downgraded Pinduoduo from Buy to Neutral and raised the price target from $48.40 to $64.

The Pinduoduo Thesis

A strong recovery in consumer demand has occurred since March following the coronavirus outbreak, and this is likely to have propelled Pinduoduo’s first-quarter performance, Ju said in the Wednesday downgrade note.

The analyst expects the company to report 40% year-on-year growth in gross merchandise value to 213 billion yuan ($31 billion) and 11% growth in revenue to 5 billion yuan.

Pinduoduo’s monetization rate is likely to have declined from 2.9% to 2.4% quarter-over-quarter

and from 3% in the first quarter of 2019 due to traffic support and subsidy to merchants, she said.

View more earnings on PDD

The company’s sales and marketing expenses are likely to have risen to 125% of revenues, up from 86% in the previous quarter and 108% in the first quarter of 2019, mainly due to lower monetization and epidemic-related subsidies, Ju said.

While traffic data indicates a reacceleration in user and engagement trends in April, the analyst expressed concern around the company’s monetization rate and profits as well as its ability to generate faster revenue growth due to competition from Alibaba Group Holding Ltd (NYSE: BABA) and JD.Com Inc (NASDAQ: JD).

PDD Price Action

Shares of Pinduoduo were down 3.47% at $60.90 at the close Wednesday.

Option Traders Betting Big On Pinduoduo Following Latest Trade Negotiation News

Latest Ratings for PDD

May 2020	B of A Securities	Downgrades	Buy	Neutral
Apr 2020	KeyBanc	Maintains		Overweight
Apr 2020	Credit Suisse	Upgrades	Neutral	Outperform

View More Analyst Ratings for PDD
View the Latest Analyst Ratings

See more from Benzinga

‘Americans just work harder’ than Europeans, says CEO of Norway’s $1.6 trillion oil fund, because they have a higher ‘general level of ambition’
"We are not very ambitious. I should be careful about talking about work-life balance, but the Americans just work harder.”
Fortune•1d ago
Warren Buffett Says 'When It Rains Gold, Put Out The Bucket' And This High Yield Investment Is Making It Rain
In his 2016 letter to Berkshire Hathaway shareholders, legendary investor Warren Buffett wrote, “Every decade or so, dark clouds will fill the economic skies, and they will briefly rain gold. When downpours of that sort occur, it’s imperative that we ...
Benzinga•19h ago
If I Had to Construct a Portfolio of Just 5 ETFs, Here's Exactly What I'd Buy Right Now
It's possible to construct a winning long-term investment strategy with just low-cost index funds.
Motley Fool•4h ago
The US economy may be barrelling towards stagflation, an outcome worse than recession
As US growth shows signs of sputtering and inflation keeps rising, a re-run of the tumultuous 1970s is looking more likely.
Business Insider•10h ago
1 Unstoppable Stock That Could Join Microsoft, Apple, Nvidia, Alphabet, Amazon, and Meta in the $1 Trillion Club
The combination of artificial intelligence (AI) and cybersecurity is a match made in heaven.
Motley Fool•5h ago
Rooting for Trump to fail has made his stock shorters millions
Rooting for Donald Trump to fail has rarely been this profitable. Just ask a hardy band of mostly amateur Wall Street investors who have collectively made tens of millions of dollars over the past month by betting that the stock price of his social media business — Truth Social — will keep dropping despite massive buying by Trump loyalists and wild swings that often mirror the candidate’s latest polls, court trials and outbursts on Trump Social itself.
Associated Press Finance•9h ago
AbbVie lifts profit forecast after Skyrizi sales beat expectations
(Reuters) -AbbVie raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates for the first quarter. Shares of AbbVie rose nearly 2.5% in premarket trading. The company now expects adjusted profit of between $11.13 and $11.33 per share for this year, compared with $10.97 to $11.17 estimated earlier.
Reuters•56m ago
Investors brace for 5% Treasury yields as US inflation worries mount
As U.S. inflation worries grow, some investors are preparing for the 10-year U.S. Treasury yield to breach a 16-year high of 5% hit last October. Bond yields, which move inversely to prices, have climbed in recent weeks as signs of persistent inflation erode expectations for how deeply the Federal Reserve will be able to cut interest rates without further fueling consumer prices. Many investors are betting further weakness lies ahead for bonds.
Reuters•8h ago
1 Unstoppable Artificial Intelligence (AI) Stock to Buy and Hold Forever
This company should continue to make millionaires, just as it has over the past two decades.
Motley Fool•1h ago
Microsoft beats Q3 top and bottom lines on cloud strength
Microsoft reported better than anticipated Q3 earnings on Thursday, powered by growth in its cloud products.
Yahoo Finance•3h ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

BofA Downgrades Pinduoduo On Monetization Concerns

Recommended Stories

‘Americans just work harder’ than Europeans, says CEO of Norway’s $1.6 trillion oil fund, because they have a higher ‘general level of ambition’

Warren Buffett Says 'When It Rains Gold, Put Out The Bucket' And This High Yield Investment Is Making It Rain

If I Had to Construct a Portfolio of Just 5 ETFs, Here's Exactly What I'd Buy Right Now

The US economy may be barrelling towards stagflation, an outcome worse than recession

1 Unstoppable Stock That Could Join Microsoft, Apple, Nvidia, Alphabet, Amazon, and Meta in the $1 Trillion Club

Rooting for Trump to fail has made his stock shorters millions

AbbVie lifts profit forecast after Skyrizi sales beat expectations

Investors brace for 5% Treasury yields as US inflation worries mount

1 Unstoppable Artificial Intelligence (AI) Stock to Buy and Hold Forever

Microsoft beats Q3 top and bottom lines on cloud strength